Inventor · disambiguated record
Mark Oliveira
Also filed as: OLIVEIRA MARK
6 granted patents·8 pending applications·11 citations·filing 2003–2012
75Inventor score
Files withTRANSFORM PHARMACEUTICALS INC4CEPHALON INC3BOEHRINGER INGELHEIM PHARMA1HICKEY MAGALI BOURGHOL1MCNEIL PPC INC1
Top patents by PatentIndex Score
14 records- 0176US8362062B2Pharmaceutical compositions with improved dissolutionMCNEIL PPC INC·Filed 2003·Granted Jan 29, 2013·5 cites·15 claims
- 0269US7763112B2Methods and systems for co-crystal synthesisTRANSFORM PHARMACEUTICALS INC·Filed 2006·Granted Jul 27, 2010·1 cites·12 claims
- 0368US8338646B2Modafinil compositionsHICKEY MAGALI BOURGHOL·Filed 2010·Granted Dec 25, 2012·1 cites·4 claims
- 0467US7566805B2Modafinil compositionsCEPHALON INC·Filed 2004·Granted Jul 28, 2009·4 cites·53 claims
- 0557US8809586B2Modafinil compositionsCEPHALON INC·Filed 2012·Granted Aug 19, 2014·0 cites·20 claims
- 0656US2005025791A1Pharmaceutical compositions with improved dissolutionFiled 2003·Application pending·0 cites
- 0752US7671093B2Mixed co-crystals and pharmaceutical compositions comprising the sameTRANSFORM PHARMACEUTICALS INC·Filed 2005·Granted Mar 2, 2010·0 cites·2 claims
- 0852US2009018202A1Modafinil compositionsCEPHALON INC·Filed 2005·Application pending·0 cites
- 0950US2006287392A1Gabapentin compositionsTRANSFORM PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 1047US2006052432A1Pharmaceutical compositions with improved dissolutionREMENAR JULIUS·Filed 2003·Application pending·0 cites
- 1143US2004214893A1Gabapentin compositionsFiled 2004·Application pending·0 cites
- 1243US2006246009A1Novel Crystalline Forms of Tiotropium BromideBOEHRINGER INGELHEIM PHARMA·Filed 2006·Application pending·0 cites
- 1341US2009091740A1Methods and systems for analyzing solidsTRANSFORM PHARMACEUTICALS INC·Filed 2005·Application pending·0 cites
- 1438US2008287542A1Novel Isovaleramide Forms, Compositions Thereof, and Related Methods of UseOLIVEIRA MARK·Filed 2006·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →